Indeed, the PPS will have a major lift off. Question is when? Rett trial readout and Alz phase 3 trial start will likely be coincident (plus/minus). No doubt, it will happen... and likely before June. Longs need to just wait it out. It'll all materialize with a valuation north of $100/sh by 2019, if not bought out this year. Either way, AVXL shareholders will be handsomely rewarded.
I agree I do not know what the short interest was on that stock but I would be very surprised if it was close to the 4 millions or so held short in Anavex. This might provide additional propellant in the form of 4 million shares forced to purchase AVXL at any price. The same might happen with a surprise announcement of a partnership that validates Anavex technology or a announcement of major import of any positive matter. I am not counting on that or holding my breath but it is just the nature of shorting Biotechs that it is a quick easy money play that takes on characteristics of Russian Roulette. The long players can hold for as long as it takes to reach approval the short players are only in the game until the bullet (event) enters the chamber the trigger is pulled and the short game is over. Any number of events could act like that bullet especially in a stock so heavily shorted and oversold such as AVXL. I could name at least six. Long Anavex.
News 
Market Data 
Discover 
AI
